Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future Perspectives - Hodowanec - 2019 - The Journal of Clinical Pharmacology - Wiley Online Library
Human betaherpesvirus 5 - Wikipedia
The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase | Journal of Virology
Pharmacology of letermovir and maribavir. | Download Scientific Diagram
![PDF] New therapies for human cytomegalovirus infections. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/07aaa387aabba58c807f4742eefbb7874ade0d0d/48-Figure7-1.png "PDF] New therapies for human cytomegalovirus infections. | Semantic Scholar")
PDF] New therapies for human cytomegalovirus infections. | Semantic Scholar
Letermovir for prophylaxis of cytomegalovirus manifestations in adult allogeneic hematopoietic stem cell transplant recipients | Future Microbiology
Introduction - Clinical Review Report: Letermovir (Prevymis) - NCBI Bookshelf
Letermovir - LiverTox - NCBI Bookshelf
Figure 1 from New therapies for human cytomegalovirus infections. | Semantic Scholar
Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation | NEJM
Letermovir | C29H28F4N4O4 - PubChem
![PDF] Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/25353d1c802fba785bea376c53270ab6fd0dd517/6-Figure1-1.png "PDF] Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus | Semantic Scholar")
PDF] Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus | Semantic Scholar
PDF) Letermovir and inhibitors of the terminase complex: A promising new class of investigational antiviral drugs against human cytomegalovirus
Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance - ScienceDirect
Development of a high-content screen for the identification of inhibitors directed against the early steps of the cytomegalovirus infectious cycle - ScienceDirect
Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation | NEJM
Letermovir - Wikipedia
Maribavir, brincidofovir and letermovir: Efficacy and safety of new antiviral drugs for treating cytomegalovirus infections - ScienceDirect
EX-99.1 2 v379095_ex99-1.htm EXHIBIT 99.1 Exhibit
Letermovir: First Global Approval | SpringerLink
Letermovir drug review
Frontiers | The Signaling Pathways, and Therapeutic Targets of Antiviral Agents: Focusing on the Antiviral Approaches and Clinical Perspectives of Anthocyanins in the Management of Viral Diseases | Pharmacology
Diagnosis and Discussion -- Case 1074
Mechanisms of action of systemic antivirals approved for treatment of... | Download Scientific Diagram
Frontiers | Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules | Microbiology
New therapies for human cytomegalovirus infections - ScienceDirect
The human cytomegalovirus terminase complex as an antiviral target: a close-up view. - Abstract - Europe PMC
Human cytomegalovirus infection: A considerable issue following allogeneic hematopoietic stem cell transplantation (Review)
